Inhibition of hepatic fatty acid oxidation by bezafibrate and bezafibroyl CoA.

[1]  P. Eacho,et al.  Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone. , 1988, The Biochemical journal.

[2]  B. Lake,et al.  Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship. , 1988, Biochemical pharmacology.

[3]  C. Elcombe,et al.  Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. , 1986, Environmental health perspectives.

[4]  M. Bronfman,et al.  Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters. , 1986, The Biochemical journal.

[5]  J. Bridges,et al.  Time and dose study on the response of rats to the hypolipidaemic drug fenofibrate. , 1986, Toxicology.

[6]  P. Eacho,et al.  Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species. , 1986, Toxicology and applied pharmacology.

[7]  J. Bridges,et al.  Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate. , 1985, Toxicology and applied pharmacology.

[8]  H. Osmundsen,et al.  Inhibitory effects of some long-chain unsaturated fatty acids on mitochondrial beta-oxidation. Effects of streptozotocin-induced diabetes on mitochondrial beta-oxidation of polyunsaturated fatty acids. , 1985, The Biochemical journal.

[9]  G. Cook,et al.  Alteration of the apparent Ki of carnitine palmitoyltransferase for malonyl-CoA by the diabetic state and reversal by insulin. , 1985, The Journal of biological chemistry.

[10]  T. Suga,et al.  Enhancement of peroxisomal beta-oxidation in the liver of rats and mice treated with valproic acid. , 1985, Biochemical pharmacology.

[11]  J. Bremer,et al.  Carnitine palmitoyltransferase. Activation by palmitoyl-CoA and inactivation by malonyl-CoA. , 1985, Biochimica et biophysica acta.

[12]  L. Weaner,et al.  Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria. , 1984, The Journal of biological chemistry.

[13]  T. Flatmark,et al.  Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators. , 1984, European journal of biochemistry.

[14]  R. Okita,et al.  Induction of laurate ω-hydroxylase by di (2-ethylhexyl)phthalate in rat liver microsomes , 1984 .

[15]  D. Turnbull,et al.  The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations. , 1984, Biochemical pharmacology.

[16]  J. Reddy,et al.  Evaluation of Selected Hypolipidemic Agents for the Induction of Peroxisomal Enzymes and Peroxisome Proliferation in the Rat Liver , 1983, Human toxicology.

[17]  M. Thomassen,et al.  Characterization of the stimulatory effect of high-fat diets on peroxisomal beta-oxidation in rat liver. , 1982, The Biochemical journal.

[18]  T. Orton,et al.  The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[19]  J. Bremer,et al.  Metabolism of very long-chain monounsaturated fatty acids (22:1) and the adaptation to their presence in the diet. , 1982, Journal of lipid research.

[20]  D. Turnbull,et al.  Increased activity of peroxisomal beta-oxidation in rat liver caused by ethyl 2(5(4-chlorophenyl)pentyl)-oxiran-2-carboxylate: an inhibitor of mitochondrial beta-oxidation. , 1982, Biochemical and biophysical research communications.

[21]  P. Eacho,et al.  Metabolism of p-nitroanisole and aniline in isolated hepatocytes of streptozotocin-diabetic rats. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[22]  M. Thomassen,et al.  Induction of peroxisomal beta-oxidation in rat liver by high-fat diets. , 1980, The Biochemical journal.

[23]  Suga Tetsuya,et al.  Clofibrate-like effects of acetylsalicylic acid on peroxisomes and on hepatic and serum triglyceride levels. , 1979 .

[24]  Hashimoto Takashi,et al.  Effects of administration of di-(2-ethylhexyl)phthalate on rat liver mitochondria. , 1978 .

[25]  N. Tolbert,et al.  Differential increase of hepatic peroxisomal, mitochondrial and microsomal carnitine acyltransferases in clofibrate-fed rats. , 1977, Biochemical pharmacology.

[26]  J. Bremer,et al.  Monoethlenic C20 and C22 fatty acids in marine oil and rapeseed oil. Studies on their oxidation and on their relative ability to inhibit palmitate oxidation in heart and liver mitochondria. , 1977, Biochimica et biophysica acta.

[27]  S. Colowick,et al.  Methods in Enzymology , Vol , 1966 .